Simon Freeman

Business

FTSE suffers £100bn meltdown as sell-off grows on Ukraine nuclear fear

- FTSE 100 sinks 3%, following 2.6% fall in previous session

- British Chamber of Commerce slashes UK growth forecast after ‘significant deterioration’

- City economists warns inflation set to be above 7% for the rest of the year

By Oscar Williams-GrutSimon FreemanSimon English
4 Mar 2022
Business

Children’s care home operators ‘profiting from failing system’

By Simon Freeman
22 Oct 2021
Pharmaceuticals

Inside the unique $1bn biotech pumping DNA from an old waterworks

By Simon Freeman
21 Oct 2021
Business

Cannabis firm backed by supermodels OTO raises £2.6m in 12 hours

By Simon Freeman
14 Oct 2021
Business

Underwater robot start-up reports success in North Sea trials

By Simon Freeman
12 Oct 2021
Pharmaceuticals

GSK to quit London HQ as £70bn drugmaker pushes button on split

By Simon Freeman
11 Oct 2021
Business

Royal Mail goes west with £210m buy-up of Canada trucking giant

By Simon Freeman
8 Oct 2021
Business

KPMG launches $1.5 billion sustainability drive in run-up to COP26

By Simon Freeman
5 Oct 2021
Business

Oxford Nanopore shares rocket 45% in blockbuster biotech debut

By Simon Freeman
30 Sept 2021
Business

Rolls-Royce to stop making petrol and diesel cars by 2030

By Simon Freeman
29 Sept 2021
Pharmaceuticals

AstraZeneca buys life sciences pioneer Caelum in $500m deal

By Simon Freeman
29 Sept 2021
Pharmaceuticals

GlaxoSmithKline bolsters pipeline with two future HIV blockbusters

By Simon Freeman
28 Sept 2021
Pharmaceuticals

Silence Therapeutics, the biotech on a mission to mute genetic disease

By Simon Freeman
25 Sept 2021
Technology & Media

Netflix joins forces with Roald Dahl Story Company

By Simon Freeman
22 Sept 2021
BRITAIN-ENERGY-GAS-POLITICS
Energy & Mining

Industry sounds alarm as gas price crisis “spiralling out of control”

By Simon Freeman
21 Sept 2021
Business

Major funds sell-off as Marlboro-maker PMI takes control of Vectura

By Simon Freeman
17 Sept 2021
Pharmaceuticals

Marlboro maker Philip Morris takes control of asthma inhaler maker

By Simon Freeman
16 Sept 2021
Pharmaceuticals

The $3bn British robot start-up shaping the future of surgery

By Simon Freeman
10 Sept 2021
Pharmaceuticals

DNA tech firm Oxford Nanopore plots £2.5billion float in London

By Simon Freeman
9 Sept 2021
Business

EasyJet shares nosedive as airline rejects takeover from rival

By Simon Freeman
9 Sept 2021
FILES-BRITAIN-METALS-TRADING-ECONOMY
Business

London Metal Exchange’s historic “ring” reopens in the City

By Simon Freeman
6 Sept 2021
12345...